-
Topics
- All Topics
- Self Care
- Blood & Skin
- Cancer & Screening
- Cardiovascular & Respiratory
-
Children & Family
- Child Emotional Wellbeing & Mental Health
- Children, Young People & Family
- Domestic Violence & Abuse
- Female Genital Mutilation
- Gender Identity
- Homelessness
- Learning Disabilities & Neurodevelopmental Disorders
- Migrant Health
- Safeguarding Adults
- Safeguarding Children
- Sexual Health
- Social Prescribing
- Speech & Language Therapy
- Diabetes & Endocrine
- Diagnostics & Investigations
- Frailty & Complex Care
- Gastroenterology, Colorectal, Renal & Urology
- Head, Neck & Eyes
- Infectious Diseases
- Mental Health
- MSK
- Neurology & Neurosurgery
- Nutrition & Weight Management
- Obstetrics & Gynaecology
- Social Care & Safeguarding
- Urgent & Emergency
- Pathways
-
Medicines
- Community Pharmacy
- Controlled Drugs Accountable Officer
- Electronic Prescription Service
- Infections and Antibiotics
- Medicines Compliance
- Medicines Management Teams: NCL
- Medicines Optimisation Prescribing Policies
- Medicines Supply Issues
- Opioids and Dependence-forming Medications
- Patient Group Directions
- Prescribing Guidelines
- Prescribing Quality Scheme (PQS)
- Prescribing Recommendations (NPR)
- Prescribing Watch
- Self-Care Medicines Scheme (SCMS)
- Shared Care
- Fact Sheets
-
Practice Management
- Cancer Care Resources
- Deadlines
- Enhanced Services
- General Practice Access Support
- General Practice Staff Survey
- Greener NCL: Sustainable General Practice
- Hospital Bypass Contacts
- Immunisations & Vaccinations
- Interface Consensus
- Practice Vacancies
- Referral Support
- Research Opportunities
- Submit a Patient Safety Incident Report
- Submit a Quality Alert
- Support for Staff
- Veterans’ Healthcare
- Education
- Digital
- Home
- Cancer Care Resources
- Early cancer diagnosis DES and QOF guidance 2024-25
Early cancer diagnosis DES and QOF guidance 2024-25
NCL WideWelcome to the NCL Direct Enhanced Service (DES) and Quality and Outcomes Framework (QOF) landing page.
This guidance has been developed with the support of wider stakeholders.
North Central London (NCL) has had the best one-year survival in England for combined cancer sites for the last six years and has the joint highest five-year survival for patients diagnosed in 2016 (latest published data). Our hypothesis is that our good survival outcomes are in part linked to high referral rates for suspected cancer, where NCL is in the top quartile nationally.
North Central London Cancer Alliance (NCLCA) wants to build on these achievements and this document provides an overview of cancer objectives for 2024/25. Our focus is on delivering activities in line with the QOF and DES for cancer, notably:
- Supporting referral practice, focused on primary care’s delivery of the Directed Enhanced Service (DES) contract.
- The latest National Cancer Patient Experience Survey (2022) explored patient experience across North Central London, outlining areas where we can make local improvements. At a primary care level, challenges around Cancer Care Reviews were highlighted; only 17.5% of respondents thought they had a Cancer Care Review. This page includes resources on carrying out Cancer Care Reviews within twelve months of diagnosis, as well as offering support discussions three months after a patient’s diagnosis of cancer.
Key contacts
Practices are encouraged to get in touch if they have any queries or would like any additional advice or support. The NCL Cancer Team would be happy to attend a scheduled peer-to-peer learning event, provide support to identify unwarranted variation via use of the revised dynamic primary care network cancer dashboard, and more.
- NCL Cancer Alliance: uclh.ncl.primarycarecancer@nhs.net
- Dr Clare Stephens, Cancer Clinical Senior Responsible Officer at NCL ICB: clare.stephens@nhs.net
- Oli Gregory, representing the NCL Cancer Alliance and leading the delivery of the alliance’s primary care workstream: ogregory@nhs.net
- Dr Zareena Cuddis, NCL Cancer Alliance Clinical Lead GP (Barnet): z.cuddis@nhs.net
- Dr Nitika Silhi, NCL Cancer Alliance Clinical Lead GP (Enfield): n.silhi@nhs.net
- Dr Kate Rees, NCL Cancer Alliance Clinical Lead GP (Haringey): k.rees@nhs.net
- Dr Seema Choudhari, NCL Cancer Alliance Clinical Lead GP (Camden): seema.chaudhari@nhs.net
Review date: Saturday, 31 May 2025